Back to search results

DREAM Intervention for Latinx Adolescents with Type 1 Diabetes

This study is testing a program called DREAM (Device use Reimagined through Education And Mentorship) for Latinx adolescents aged 13-17 with type 1 diabetes. The DREAM program uses virtual peer groups (VPGs) to help participants learn about and use diabetes technology like insulin pumps and continuous glucose monitors. These VPGs will cover topics such as diabetes technology and family relationships. The goal is to see if the DREAM program can help improve how often and how well Latinx adolescents use these devices, which can lead to better blood sugar control. To join, you must be a Latinx adolescent with type 1 diabetes receiving care at UCSF, CHLA, or UC Davis, and your preferred language is English or Spanish. The study is currently unclear on its recruitment status.

Study design
This is an interventional study with a planned enrollment of 120 participants. It is a single-arm trial, meaning all participants will receive the DREAM intervention.
What's involved
Participants will have multiple chances to attend virtual peer groups on specific topics during their 6-12 month participation period.
Compensation
Not stated in the trial record.
Follow-up
Caregivers will complete surveys at the beginning of the study, at the end of the study (6-15 months), and throughout the study (up to 15 months).

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06546930

Device Use Reimagined Through Education And Mentorship

Active, Not Recruiting
NAAges 13–17InterventionalSupportive care
University of California, San Francisco
~120 participants
Updated 2026-05-01 on ClinicalTrials.gov
What's tested:DREAM intervention

At a glance

Recruiting sites
0 of 3 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Caregiver Survey
Measured over Baseline
+9 more outcomes measured

Conditions

Diabetes Mellitus, Type 1

Explore related trials

Type 1 Diabetes Mellitus

Where it's being run

3 sites across 1 states
California3

Study leadership

  • Jenise C Wong, MD, PhD · PRINCIPAL_INVESTIGATOR · University of California, San Francisco

Who to contact

This trial hasn't published a contact. View it on ClinicalTrials.gov

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Adolescents 13-17 years old and their caregivers
Adolescent must have T1D of any duration, and be receiving diabetes care at UCSF, CHLA or UC Davis
Self-identify as Latina/o/x or other variations such as Hispanic
Preferred language of English or Spanish

Exclusion

Participants who have a medical, developmental, or psychiatric condition that would make peer group participation difficult
Adolescents who are planning to transfer care to a different medical center within the next year, which would prevent assessment of longitudinal outcomes

What this trial measures

  • Caregiver SurveyBaseline

    Captures personal and family background (e.g. gender, income)

  • Caregiver Phase 2 Intervention Survey - "Feedback Survey"End of Study to (6-15 months)

    Assess various intervention components (e.g., frequency of virtual peer groups, in person events).

  • Caregiver In Person Event EvaluationThroughout the study, up to 15 months

    Captures in the moment in person event feedback (e.g., improve experience and components).

  • Caregiver Online Group EvaluationThroughout the study, up to 15 months

    Captures moment group feedback (e.g., improve experience and content).

  • Adolescent SurveyBaseline

    Captures diabetes technology, personal and family background (e.g., diabetes technology history, gender).

  • Adolescent Phase 2 Intervention Survey - "Feedback Survey"End of Study (6-15 months)

    Assess various intervention components (e.g, frequency of virtual peer groups, in person events).

  • Adolescent In Person Event EvaluationThroughout the study, up to 15 months

    Captures in the moment in person event feedback (e.g., improve experience and components).

  • Adolescent Online Group EvaluationThroughout the study, up to 15 months

    Captures moment group feedback (e.g., improve experience and content).

  • Attendance at VPG and in-person eventsThroughout the study, up to 15 months

    Attendance will be recorded for each in person and online events

  • Retention of enrolled patientsEnd of Study (6-15 months)

    Engagement of participants throughout study trajectory